A Study of the Safety and Effectiveness of Ustekinumab in Patients With Psoriatic Arthritis
Clinical trial NCT01009086 · COMPLETED
Trial details
- NCT number
- NCT01009086
- Sponsor
- Janssen Research & Development, LLC
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2009-12-01
- Primary completion
- 2011-10-01
- Enrollment
- 615
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.